These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11342165)

  • 1. Characterization of sterically stabilized cisplatin liposomes by nuclear magnetic resonance.
    Peleg-Shulman T; Gibson D; Cohen R; Abra R; Barenholz Y
    Biochim Biophys Acta; 2001 Feb; 1510(1-2):278-91. PubMed ID: 11342165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metallomics in drug development: characterization of a liposomal cisplatin drug formulation in human plasma by CE-ICP-MS.
    Nguyen TT; Østergaard J; Stürup S; Gammelgaard B
    Anal Bioanal Chem; 2013 Feb; 405(6):1845-54. PubMed ID: 23052859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Encapsulation, controlled release, and antitumor efficacy of cisplatin delivered in liposomes composed of sterol-modified phospholipids.
    Kieler-Ferguson HM; Chan D; Sockolosky J; Finney L; Maxey E; Vogt S; Szoka FC
    Eur J Pharm Sci; 2017 May; 103():85-93. PubMed ID: 28263913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing mice.
    Newman MS; Colbern GT; Working PK; Engbers C; Amantea MA
    Cancer Chemother Pharmacol; 1999; 43(1):1-7. PubMed ID: 9923534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of platinum drug release and liposome stability in human plasma by CE-ICP-MS.
    Nguyen TT; Ostergaard J; Stürup S; Gammelgaard B
    Int J Pharm; 2013 Jun; 449(1-2):95-102. PubMed ID: 23583709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of phospholipid on the physicochemical properties and anti-tumor efficacy of liposomes encapsulating cisplatin in mice bearing C26 colon carcinoma.
    Alavizadeh SH; Badiee A; Golmohammadzadeh S; Jaafari MR
    Int J Pharm; 2014 Oct; 473(1-2):326-33. PubMed ID: 25051111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved pharmacological profile of the lipophilic antitumor dichloro-(N-dodecyl)-propanediamine-platinum(II) complex after incorporation into pegylated liposomes.
    Silva H; Silva AC; Lemos FO; Monte-Neto RL; Fontes AP; Lopes MT; Frézard F
    Anticancer Drugs; 2013 Feb; 24(2):131-9. PubMed ID: 23011234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin.
    Meerum Terwogt JM; Groenewegen G; Pluim D; Maliepaard M; Tibben MM; Huisman A; ten Bokkel Huinink WW; Schot M; Welbank H; Voest EE; Beijnen JH; Schellens JM
    Cancer Chemother Pharmacol; 2002 Mar; 49(3):201-10. PubMed ID: 11935212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caprylate-conjugated Cisplatin for the development of novel liposomal formulation.
    Vhora I; Khatri N; Desai J; Thakkar HP
    AAPS PharmSciTech; 2014 Aug; 15(4):845-57. PubMed ID: 24700295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular and serum stability of liposomal 2',3'-dideoxycytidine. Effect of lipid composition.
    Makabi-Panzu B; Gourde P; Désormeaux A; Bergeron MG
    Cell Mol Biol (Noisy-le-grand); 1998 Mar; 44(2):277-84. PubMed ID: 9593578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic and structural aspects of PEGylated liposomes monitored by NMR.
    Leal C; Rögnvaldsson S; Fossheim S; Nilssen EA; Topgaard D
    J Colloid Interface Sci; 2008 Sep; 325(2):485-93. PubMed ID: 18589432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-circulating sterically stabilized liposomes in the treatment of infections.
    Bakker-Woudenberg IA; Schiffelers RM; Storm G; Becker MJ; Guo L
    Methods Enzymol; 2005; 391():228-60. PubMed ID: 15721385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting microencapsulation of drugs in liposomes.
    Kulkarni SB; Betageri GV; Singh M
    J Microencapsul; 1995; 12(3):229-46. PubMed ID: 7650588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin nanoliposomes for cancer therapy: AFM and fluorescence imaging of cisplatin encapsulation, stability, cellular uptake, and toxicity.
    Ramachandran S; Quist AP; Kumar S; Lal R
    Langmuir; 2006 Sep; 22(19):8156-62. PubMed ID: 16952256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing the therapeutic efficacy of cisplatin PEGylated liposomes via incorporation of different DPPG ratios: In vitro and in vivo studies.
    Marzban E; Alavizadeh SH; Ghiadi M; Khoshangosht M; Khashayarmanesh Z; Abbasi A; Jaafari MR
    Colloids Surf B Biointerfaces; 2015 Dec; 136():885-91. PubMed ID: 26547316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumours.
    Gabizon A; Martin F
    Drugs; 1997; 54 Suppl 4():15-21. PubMed ID: 9361957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ET AAS evaluation of the stability and pH-sensitivity of, pH-sensitive stealth liposomes containing cisplatin in mouse plasma.
    Vieira FP; Mesquita TL; Lara PC; Ramaldes GA; Beinner MA; Silva JB; Oliveira MC; Silveira JN
    J Pharm Biomed Anal; 2013 Oct; 84():135-9. PubMed ID: 23831488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomal delivery of hydrophobic weak acids: enhancement of drug retention using a high intraliposomal pH.
    Joguparthi V; Anderson BD
    J Pharm Sci; 2008 Jan; 97(1):433-54. PubMed ID: 17918731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposome transport of hydrophobic drugs: gel phase lipid bilayer permeability and partitioning of the lactone form of a hydrophobic camptothecin, DB-67.
    Joguparthi V; Xiang TX; Anderson BD
    J Pharm Sci; 2008 Jan; 97(1):400-20. PubMed ID: 17879989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of loading procedures of magnetic nanoparticles on the structure and physicochemical properties of cisplatin magnetic liposomes.
    Wang L; Yang CQ; Wang J
    J Microencapsul; 2012; 29(8):781-9. PubMed ID: 22657750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.